During today’s plenary lunch session at BIO's 2011 World Congress in Toronto, Royal DSM CEO Feike Sijbesma gave a passionate keynote address and accepted the 2011 George Washington Carver Award for his company’s efforts to promote bio-based products over those relying on fossil-fuel resources.

BIOtechNOW’s Tracy Cooley talks to Dr. Jones about the significance and importance of the re; Biotech Humanitarian Award , which will be bestowed on this year’s award winner at the  BIO International Convention during a keynote session on Wednesday, June 29.

Bonnie Fendrock, co-founder, president, and CEO of Hepregen Corporation, talks about her career in the life-sciences industry and the work of Hepregen — including the commercialization of their microliver platform.

With global food costs reaching such dangerous levels, ensuring a safe, affordable and abundant global food supply has never been as important as it is right now.

Thanks to genetic engineering, flowers are heartier and last longer after they’re cut.  And they come in a wider variety of shapes, sizes, scents and colors – even blue!

BIO will be co-hosting an event with the United States Patent and Trademark Office (USPTO) to celebrate the 30th anniversary of the issuance of U.S. patent 4,259,444 to Ananda Chakrabarty following the Supreme Court case, Diamond v. Chakrabarty, which held that Chakrabarty’s bioengineered bacterium was eligible for patenting.

A new report analyzing FDA-approved monoclonal antibodies (mAbs) produced by a select group of leading biotechnology companies shows that clinical development times – specifically the duration of Phase II and Phase III trials – are lengthening, while FDA review times have remained constant.

BIO has named Feike Sijbesma as the recipient of its 2011 George Washington Carver Award for innovation in industrial biotechnology.

Mark Herzog, executive director of the Virginia Biotechnology Association recently discussed the success and challenges facing the burgeoning bioscience industry in his state.

"The Value Proposition for Cellulosic and Advanced Biofuels Under the Federal Renewable Fuel Standard" is forthcoming in the April 2011 Industrial Biotechnology Journal.

April is Parkinson's Awareness Month so it seemed like a good opportunity to learn more about the Michael J. Fox Foundation for Parkinson's Research.

Three biotech luminaries who have succeeded against all odds share their experiences building a biotech company from the ground up in Brazil, China and India.

BIO has named a distinguished panel of leaders to judge the third annual Biotech Humanitarian Award and select the 2011 Honoree.

Earlier this month, we asked the 2011 BIO International Convention Linkedin group if any of our veterans could provide some tips for navigating the event. The discussion was too good not to share, so we collected the best insights right here for you.

Recently the Oklahoma Bioscience Association held a 2011 BIO International Convention information session for their delegates to get ready for the June event.

Last year, stem cell advocate Robert Klein was named the 2010 Biotech Humanitarian Honoree. Who will be named this year's Honoree?

Current rules resulting from a 2003 Office of Hearings and Appeals decision have inhibited and interfered with the growth and survival of small private biotechnology companies and the development of promising technologies and products

The Agriculture Department has announced additional money for loan guarantees to support construction of new advanced biofuel biorefineries.

The Maryland initiative’s 10-year plan helps build biotech access to funding

GEN's Editor-in-Chief John Sterling outlines his picks for the top ten "must attend" breakout sessions at the 2011 BIO International Convention.

As we celebrate World Health Day today, it is an opportunity to remember that vaccines represent one of the most important global health investments.

 John Carroll, editor of Fierce Biotech, shares what he won't miss at the 2011 BIO International Convention.

As Japan works to stabilize the crippled nuclear power plant in Fukushima, people are stocking up on potassium iodide tablets – one of the only drugs available to block the body's absorption of some radioactive materials.